Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in HALOZYME THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 733,562 shares of HALO (HALOZYME THERAPEUTICS INC), worth $49.4M as of 2025-Q4. The position was increased (++124.3% shares). HALO represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$49.4M
Current Shares
733,562
Total Value Change
+$26.7M
Total Shares Change
+301,538
Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 733,562 |
+124.3% |
| $49.4M |
| 0.0% |
| $67.70 |
47 |
| 2025-Q3 | Decreased | 326,967 | -34.1% | $24M | 0.0% | $73.29 | 0 |
| 2025-Q2 | Increased | 496,344 | +19.2% | $25.8M | 0.0% | $52.21 | 34 |
| 2025-Q1 | Increased | 416,262 | +6.8% | $26.6M | 0.0% | $63.84 | 31 |
| 2024-Q4 | Decreased | 389,875 | -2.0% | $18.6M | 0.0% | $47.99 | 0 |
| 2024-Q3 | Decreased | 397,833 | -7.9% | $22.8M | 0.0% | $56.97 | 0 |
| 2024-Q2 | Increased | 432,024 | +168.4% | $22.6M | 0.0% | $52.36 | 46 |